Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elevance Health, Inc. Common Stock (NY:ELV)

388.96 +7.47 (+1.96%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
ELV: One Stock Superinvestors Are Loading Up On
Elevance Health, formerly known as Anthem, is one of the largest health insurance companies in the United States. 
Via Talk Markets
Topics Stocks / Equities
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session.
Curious about the S&P500 stocks that are showing activity before the opening bell on Tuesday? 
Via Chartmill
Elevance Health: A Healthcare Benefits Play With A Solid Dividend
Elevance Health Inc. is a healthcare benefits company serving nearly 46 million members through its plans. The company offers managed care plans to a wide range of markets. Additionally, it has an... 
Via Talk Markets
Topics Stocks / Equities
Q4 Earnings Highlights: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Is the Market Bullish or Bearish on Elevance Health?
Via Benzinga
Here's How Much $100 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
Via Benzinga
A Glimpse Into The Expert Outlook On Elevance Health Through 6 Analysts
Via Benzinga
1 Healthcare Stock to Own for Decades and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Discover which S&P500 stocks are making waves on Thursday.
Let's delve into the developments on the US markets in the middle of the day on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Which S&P500 stocks are moving on Tuesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
Elevance Health Dividend Increase
On 23 January, Elevance Health (ELV) increased its quarterly dividend by 4.91%, from $1.63 to $1.71 per share. The dividend is payable on 25 March to shareholders of record on 10 March. 
Via Talk Markets
Topics Stocks / Equities
How Is The Market Feeling About Elevance Health?
Via Benzinga
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
These S&P500 stocks are moving in today's pre-market session
Curious about the S&P500 stocks that are showing activity before the opening bell on Friday? 
Via Chartmill
Health Insurance ETFs in Focus as RFK Jr Takes Over HHS
Robert F. Kennedy Jr. has taken office as HHS secretary, which could impact the healthcare sector, including ETFs with exposure to insurers like UnitedHealth and Elevance Health. 
Via Benzinga
Topics ETFs
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
Topics Government
Humana 2025 Outlook Shows Cautious Optimism Despite Industry Pressures
Humana reported a Q4 adjusted EPS loss of $2.16 while revenue grew 13.5% year-over-year to $29.19 billion. 
Via Benzinga
Alphabet's Verily Sells Granular Insurance To Elevance Health Amid Healthcare Strategy Refocus
Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, Granular Insurance Company, to Elevance Health. 
Via Benzinga
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
Via Benzinga
Top S&P500 movers in Monday's session
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was... 
Via StockStory
5 Stocks With Above-Market Yields Just Raised Payments Further
These five stocks with dividend yields already eclipsing that of the overall market just pushed their quarterly dividend payments higher. 
Via MarketBeat
Topics ETFs Government
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people. 
Via Benzinga
Topics Government
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. 
Via MarketBeat
Topics Artificial Intelligence
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected. 
Via Stocktwits
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared. 
Via Benzinga
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
From Elevance Health, Inc.
Via Business Wire
Earnings Scheduled For January 23, 2025
Via Benzinga
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Many stocks flashed buy signals as the major indexes rose to or above key levels. 
Via Investor's Business Daily
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.